PeptidePedia The community reference

Purity claim inflation (revision 1)

Old revision·07:37, 27 Oct 2024·TelehealthTruus

This is an old revision of this page, as it stood at 07:37, 27 Oct 2024, saved by TelehealthTruus with the summary new article: testing and documentation, expansion welcome. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Purity claim inflation
Distinguished fromForgery — the figure here is genuine
MechanismMethod choice, integration, and framing
Topic infobox · conventions

Purity claim inflation is the presentation of a purity figure in a manner that overstates what it establishes. Unlike forgery, the figure is generally genuine: what is misleading is the method that produced it, the way it was integrated, or the framing that presents it as answering a question it does not answer.[1]

The most consequential form is the substitution of purity for content. An area percent figure is normalised: it describes the proportion of detected material attributable to the main peak, and it is unaffected by how much peptide is present. A vial can be 99% pure and contain half the stated mass. Presenting purity where content is the relevant question is the commonest inflation of all.[1]

Mechanisms

[edit]
MechanismEffect on the number
Short gradientClose-eluting impurities merge into the main peak
Generous integration boundariesShoulders counted as main peak
Detection wavelength chosen for the analyteImpurities absorbing elsewhere under-detected
Reporting purity in place of contentSilence on how much peptide is present
Quoting the best of several determinationsSelection from a distribution
Aggregating related substances into one figureIndividual impurities concealed

None of these is necessarily improper. A short gradient may be entirely appropriate for a well-characterised material; aggregate reporting of related substances is standard in some contexts. What makes a presentation inflationary is the gap between what the method establishes and what the figure is used to assert.[2]

References

  1. ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
  2. ^ United States Pharmacopeia, General Chapter <621>, Chromatography.